Cauris Management's Fonds Cauris Croissance II invests in Cote d'Ivoire-based pharmaceutical business, CIPHARM

01 May 2014

Abidjan, Cote d’Ivoire, April 2014: FONDS CAURIS CROISSANCE II LIMITED, advised by the West African fund manager Cauris Management, agreed to invest in CIPHARM to diversify its range of injectable pharmaceuticals products.

CIPHARM is a Cote d’Ivoire-based leading pharmaceutical company with revenues derived from 12 countries across west and central Africa. The company has been in operations for over 25 years and manufactures a broad range of generic pharmaceuticals (dry forms, syrups and powder) under its own brand names as well as licensed names.

Fonds Cauris Croissance II Limited’s investment will allow the company to diversify its range of products with injectable pharmaceuticals, for which there is an increasing demand combined with a severe lack of local production.

Commenting on this investment, Mr Ibrahima Diawara, CEO of CIPHARM said: “Fonds Cauris Croissance II investment will take the business to the next level through:
1. the launch of new products including hemodialysis solutions
2. new technical partnerships
3. the strengthening of governance and an improvement in the relationship with banks.”

“This partnership with CIPHARM is an opportunity for Cauris Management to support a leading pharmaceutical company in its growth and diversification strategy. The economic and population growths in the region generate increased needs for healthcare products and solutions, which need to be delivered it is important to address with quality and affordable care. Cauris Management will also assist the company in improving its environmental, social and governance standards” notes Mr Thierry Vissého Gnassounou, Partner at Cauris Management.

« Back to Member News

"85% of Institutional investors surveyed identify West Africa as an attractive region for PE investment over the ne… https://t.co/Yyq8rRWEne

Institutional Investors believe in the long-term attractiveness of African PE - especially when compared to develop… https://t.co/TPoVK6lC6I

RT @CDCgroup: We're very happy to announce that we'll soon be welcoming our first Chief Impact Officer. Liz Lloyd CBE will lead a team of 5…

RT @Mkessome: Global private equity managers are ready to double down on their African investments https://t.co/LzuDaoOPHa via @qzafrica @a…

@Mkessome @AVCA_Africa CEO, moderated a panel discussing the role of private equity in Africa growth story… https://t.co/JJZnU4Ko3l

;